| 000 | 01798 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250512092107.0 | ||
| 264 | 0 | _c19740827 | |
| 008 | 197408s 0 0 eng d | ||
| 022 | _a0080-2727 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHenkind, P | |
| 245 | 0 | 0 |
_aOcular manifestations of rheumatic disorders. Natural and iatrogenic. _h[electronic resource] |
| 260 |
_bRheumatology _c1973 |
||
| 300 |
_a13-59 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadverse effects |
| 650 | 0 | 4 |
_aArteritis _xcomplications |
| 650 | 0 | 4 |
_aArthritis, Juvenile _xcomplications |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xcomplications |
| 650 | 0 | 4 |
_aChloroquine _xadverse effects |
| 650 | 0 | 4 |
_aConjunctivitis _xetiology |
| 650 | 0 | 4 |
_aDermatomyositis _xcomplications |
| 650 | 0 | 4 |
_aEye Diseases _xchemically induced |
| 650 | 0 | 4 | _aEye Manifestations |
| 650 | 0 | 4 |
_aGlaucoma _xchemically induced |
| 650 | 0 | 4 |
_aGold _xadverse effects |
| 650 | 0 | 4 |
_aGranulomatosis with Polyangiitis _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxychloroquine _xadverse effects |
| 650 | 0 | 4 | _aIatrogenic Disease |
| 650 | 0 | 4 |
_aIndomethacin _xadverse effects |
| 650 | 0 | 4 |
_aKeratitis _xetiology |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xcomplications |
| 650 | 0 | 4 |
_aPolyarteritis Nodosa _xcomplications |
| 650 | 0 | 4 |
_aPolymyalgia Rheumatica _xcomplications |
| 650 | 0 | 4 |
_aRetinal Diseases _xetiology |
| 650 | 0 | 4 |
_aRheumatic Diseases _xcomplications |
| 650 | 0 | 4 | _aSclera |
| 650 | 0 | 4 |
_aScleroderma, Systemic _xcomplications |
| 650 | 0 | 4 |
_aSjogren's Syndrome _xcomplications |
| 650 | 0 | 4 |
_aSpondylitis, Ankylosing _xcomplications |
| 650 | 0 | 4 |
_aUveitis _xetiology |
| 700 | 1 | _aGold, D H | |
| 773 | 0 |
_tRheumatology _gvol. 4 _gno. 0 _gp. 13-59 |
|
| 999 |
_c4157441 _d4157441 |
||